Skip to main content

EVITA - A double-blind, vehicle controlled, randomized phase II trial of vitamin K1 cream as prophylaxis for cetuximab-induced skin toxicity.

Author
Abstract
:

Acne-like skin rash is a frequently occurring adverse event associated with drugs against the epidermal growth factor receptor. This randomized vehicle-controlled study investigated the addition of vitamin K1 cream to doxycycline in patients with metastatic colorectal cancer treated with cetuximab.

Year of Publication
:
2018
Journal
:
Annals of oncology : official journal of the European Society for Medical Oncology
Date Published
:
2018
ISSN Number
:
0923-7534
URL
:
https://academic.oup.com/annonc/article-lookup/doi/10.1093/annonc/mdy015
DOI
:
10.1093/annonc/mdy015
Short Title
:
Ann Oncol
Download citation